Therapeutic angiogenesis
- Autores: Bersenev A.V.1
-
Afiliações:
- Thomas Jefferson University
- Edição: Nº 1 (2006)
- Páginas: 47-48
- Seção: Reviews
- ##submission.dateSubmitted##: 18.01.2023
- ##submission.dateAccepted##: 18.01.2023
- ##submission.datePublished##: 06.03.2023
- URL: https://genescells.ru/2313-1829/article/view/125132
- DOI: https://doi.org/10.23868/gc125132
- ID: 125132
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
The review is devoted to the search for new [non-hematopoietic] stem and progenitor cell populations of human umbilical cord blood, the possibilities of their isolation and therapeutic use. For convenience, the review is divided into several chapters, at the end of each of which there is a separate list of references.
Texto integral
Sobre autores
A. Bersenev
Thomas Jefferson University
Autor responsável pela correspondência
Email: redaktor@celltranspl.ru
Estados Unidos da América, Philadelphia
Bibliografia
- Murohara T., Ikeda Н., Duan J. et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 2000; 105(11): 1527-36.
- Kim S.Y., Park S.Y., Kim J.M. et al. Differentiation of endothelial cells from human umbilical cord blood AC133[-)CD14[+) cells. Ann. Hematol. 2005; 84(71:417-22.
- Yang C., Zhang Z.H., Li Z.J. et al. Enhancement of neovascularization with cord blood CD133+ cell-derived endothelial progenitor cell transplantation. Thromb. Haemost. 2004; 91(6): 1202-21
- Larrivee B., Karsan A. Isolation and culture of primary endothelial cells. Methods Mol. Biol. 2005; 290: 315-29.
- Aoki M„ Yasutake M„ Murohara T. Derivation of functional endothelial progenitor cells from human umbilical cord blood mononuclear cells isolated by a novel cell filtration device. Stem Cells 2004; 22(6): 994-1002.
- Ma N.. Stamm C., Kaminski A. et al. Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc. Res. 2005; 66(1): 45-54.
- Botta R., Gao E., Stassi G. et al. Heart infarct in NOD-SCID mice: therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34+KDR+ cells. FASEB J. 2004; 18(12): 1392-4.
- Pesce M„ Orlandi A., lachininoto M.G. et al. Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues. Giro. Res. 2003; 93(5): e51-62.
- Murohara T. Therapeutic vasculogenesis using human cord blood-derived endothelial progenitors. Trends Cardiovasc. Med. 2001; 11(8): 303-7.
- Leor J., Guetta E., Feinberg M.S. et al. Human umbilical cord blood-derived CD133+ cells rnhance function and repair of the infarcted myocardium. Stem Cells 2005; Oct 6; Epub.
- Kim B.O., Tian H., Prasongsukarn K. et al. Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Giro. 2005; 112(9 Suppl): I96-204.
- Henning R.J., Abu-Ali H., Balis J.U. et al. Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplant. 2004; 13(7-8): 729-39.
- Hirata Y., Sata M„ Motomura N. et al. Human umbilical cord blood cells improve cardiac function after myocardial infarction. Biochem. Biophys. Res. Commun. 2005; 327[2):.609-14.
Arquivos suplementares
